ANALYSIS OF THE EFFECT OF GALANTAMINE IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE (AD)

被引：0
作者：
Moruzzi, E. [1 ]
机构：
[1] Voila Hosp, Campina, Romania
来源：
EUROPEAN PSYCHIATRY | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
P-455
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Masitinib for the treatment of mild to moderate Alzheimer's disease
    Folch, Jaume
    Petrov, Dmitry
    Ettcheto, Miren
    Pedros, Ignacio
    Abad, Sonia
    Beas-Zarate, Carlos
    Lazarowski, Alberto
    Marin, Miguel
    Olloquequi, Jordi
    Auladell, Carme
    Camins, Antoni
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (06) : 587 - 596
  • [22] Galantamine in the treatment of Alzheimer's disease
    Latalova, K. L.
    Pidrman, V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S476 - S476
  • [23] Safety and tolerability of galantamine in mild to moderate Alzheimer's disease: a naturalistic, observational survey (ALLCARE)
    Cnockaert, X
    Tessier, C
    Hammond, G
    Foucher, A
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 311 - 312
  • [24] Galantamine for Alzheimer's disease and mild cognitive impairment
    Loy, C
    Schneider, L
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01):
  • [25] Effects of galantamine in patients with mild Alzheimer's disease
    Orgogozo, JM
    Small, GW
    Hammond, G
    Van Baelen, B
    Schwalen, S
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (11) : 1815 - 1820
  • [26] Galantamine for Alzheimer's disease and mild cognitive impairment
    Cusi, Cristina
    Cantisani, Teresa Anna
    Celani, Maria Grazia
    Incorvaia, Barbara
    Righetti, Enrico
    Candelise, Livia
    NEUROEPIDEMIOLOGY, 2007, 28 (02) : 116 - 117
  • [27] Galantamine has a broad spectrum of efficacy in mild-to-moderate Alzheimer's disease.
    Mintzer, JE
    Kershaw, P
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S23 - S23
  • [28] ZT-1 for the symptomatic treatment of mild to moderate Alzheimer disease (AD)
    Orgogozo, JM
    Tamchès, E
    Wilkinson, D
    Yancheva, ST
    Gagiano, C
    Grosgurin, P
    Porcher, H
    Scalfaro, P
    NEUROBIOLOGY OF AGING, 2006, 27 : S16 - S16
  • [29] Long-term cognitive response to galantamine in patients with mild-to-moderate Alzheimer's disease: A continuance analysis
    Raskind, M
    Peskind, E
    Kershaw, P
    Mahableshwarkar, AR
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 282 - 282
  • [30] Solanezumab for the treatment of mild-to-moderate Alzheimer's disease
    Imbimbo, Bruno P.
    Ottonello, Simone
    Frisardi, Vincenza
    Solfrizzi, Vincenzo
    Greco, Antonio
    Seripa, Davide
    Pilotto, Alberto
    Panza, Francesco
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (02) : 135 - 149
12345